TDP2 Activators

TDP2 Activators are a class of compounds that enhance the functional activity of TDP2, a 5'-tyrosyl DNA phosphodiesterase that plays a critical role in the cellular repair of DNA damage, particularly damage arising from stalled topoisomerase II cleavage complexes. The compounds listed above are primarily topoisomerase II inhibitors or DNA-damaging agents that increase the cellular demand for TDP2 activity by stabilizing DNA-topoisomerase II complexes or causing DNA breaks that TDP2 is uniquely suited to repair. Etoposide and teniposide are classic examples of TDP2 activators, as their mode of action directly produces the type of DNA lesions that TDP2 is known to repair. By stabilizing the DNA-topoisomerase II complex, they create a substrate for TDP2, which then acts to mend the DNA-protein crosslink and restore the integrity of the DNA. Doxorubicin and mitoxantrone similarly intercalate within DNA and inhibit topoisomerase II, leading to double-strand breaks and the formation of cleavage complexes that require TDP2 for resolution. Amsacrine and dexrazoxane enhance TDP2 activity by inducing topoisomerase II-mediated DNA cleavage or by chelating iron, which is necessary for the catalytic activity of topoisomerase II, respectively.

Other compounds, such as ellipticine, merbarone, and the ICRF series (ICRF-193 and ICRF-187), contribute to the activation of TDP2 by altering topoisomerase II activity or conformation, creating DNA damage that precipitates the need for TDP2-mediated repair. Sobuzoxane, through the creation of interstrand cross-links, and topotecan, as a topoisomerase I inhibitor, indirectly necessitate theenhanced function of TDP2 by adding to the complex network of DNA damage and repair in which TDP2 is a critical player. Notably, while topotecan primarily targets topoisomerase I, the resulting single-strand breaks can indirectly enhance TDP2 activity due to the interplay between different DNA repair pathways that attempt to resolve the complex DNA damage response.